Guidance
Evidence-based recommendations on enzyme-linked immunosorbent assay (ELISA) tests for therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors in rheumatoid arthritis. The tests are Promonitor, IDKmonitor, LISA‑tracker, RIDASCREEN, MabTrack, and those used by Sanquin Diagnostic Services.
Is this guidance up to date?
Next review: 2022
Guidance development process
How we develop NICE diagnostics guidance
This guidance replaces the NICE medtech innovation briefing on promonitor for monitoring response to biologics in rheumatoid arthritis (MIB126).